HeyJaredProstate Cores
Prostate Cores includes abstracts (brief summaries) of research on ActiveSurveillance, low-risk to favorable intermediate-risk prostate cancer, BPH (benign prostatic hyperplasia), and prostatitis.
- Indexed issues, last 90 days
- 3
- Latest publication
- Sep 6, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 3, 2026
Latest issues
A New Drug Combination Takes Aim at Resistant Prostate Cancer (opens the original)
Read excerpt
By Howard Wolinsky, Editor, Prostate CoresA new experimental treatment is being tested in men with advanced prostate cancer that has learned how to keep growing despite drugs designed to shut down the male-hormone signals that help drive the disease.Monte Rosa Therapeutics announced Aug. 24 that the first patient has been treated in MODeFIRe-1, a Phase 2 clinical trial testing its experimental drug MRT-2359 together with apalutam
Paid subscribers sign up to hear Dr. Scott Eggener as first speaker in blockbuster AS27 webinar set for January 14, 2027 (opens the original)
Read excerpt
By Howard Wolinsky, Editor, The Active SurveillorPaid subscribers like you keep Prostate Cores alive, and I thank you. Your one annual perk is my free, live webinar with the top minds in Active Surveillance, who answer your questions in real time.Register now with your name and email: https://us02web.zoom.us/meeting/register/5y_M5fLTSG-phAA8R6uXzw<span
From Middle Fingers to Micro‑Moves: How AI Is Rewriting Prostate Surgery (opens the original)
Read excerpt
By Howard Wolinsky, Editor, Prostate CoresAfter prostate surgery, some men feel like the only gesture they have left is the middle finger—aimed at the surgeon, the cancer, or the cosmic unfairness of urinary leakage and erectile dysfunction. It’s a natural response. When your body isn’t cooperating, your hands sometimes say what your mouth won’t.But Cedars‑Sinai researchers in LA are focusing on a very different kind of gesture: the ones surgeons make during the operation. <div class="cap
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.